Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.
Press releases published on July 1, 2025
CarGurus Launches a Summer of Giveaways Alongside New ‘Big Deal’ Video Series Celebrating Life’s Biggest Moments
GlobeNewswire
·
July 1, 2025
“The Big Deal Show” brings together fan-favorites in sports and entertainment to share their defining moments — and help CarGurus celebrate “big deals” with three car giveaway winners BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), …
Columbia Forest Products Streamlines M&A Pipeline with Midaxo
GlobeNewswire
·
July 1, 2025
BOSTON and GREENSBORO, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- Columbia Forest Products, the largest manufacturer of hardwood veneer and hardwood plywood in the U.S., has transformed its M…
Mahindra Selects Cerence Audio AI to Power In-Car Voice Interaction in its Electric Origin SUVs
GlobeNewswire
·
July 1, 2025
BURLINGTON, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global industry leader in AI for transportation, today announced that Mahindra has selected Cerence Audio AI to enhance in-car interaction in its next- …
DIH Appoints Rehazentrum Valens as a DIH Center of Excellence
GlobeNewswire
·
July 1, 2025
NORWELL, Mass., and ZÜRICH, Switzerland, July 01, 2025 (GLOBE NEWSWIRE) -- DIH HOLDING US, Inc. (“DIH”) (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to …
Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
GlobeNewswire
·
July 1, 2025
SAN FRANCISCO and VANCOUVER, British Columbia, July 01, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the appointment …
Apellis to Receive up to $300 Million from Royalty Purchase Agreement with Sobi for Ex-U.S. Royalties of Aspaveli® (systemic pegcetacoplan)
GlobeNewswire
·
July 1, 2025
Apellis to receive $275 million upfront and up to $25 million in milestone payments upon EMA approval in C3G and IC-MPGN Non-dilutive financing further strengthens Apellis’ balance sheet Apellis retains full U.S. commercialization rights for systemic …
Parexel announces appointments of two FDA luminaries – Lola Fashoyin-Aje, M.D., MPH and Tala Fakhouri, Ph.D., MPH – to its Consulting team, further strengthening regulatory, medical and AI expertise
GlobeNewswire
·
July 1, 2025
DURHAM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced two Food and Drug …
Lumina Datamatics recognized with the ET Now Best Organisations to Work 2025 Award
GlobeNewswire
·
July 1, 2025
MUMBAI, India, July 01, 2025 (GLOBE NEWSWIRE) -- Lumina Datamatics, a strategic partner to global publishers and eCommerce retailers, is delighted to announce that it has been honored with the ET Now Best Organisations to Work 2025 Award on Wednesday, June …
Payscale Expands Global Footprint with Bucharest Technology Hub
GlobeNewswire
·
July 1, 2025
BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Payscale Inc., the leading provider of compensation intelligence solutions, today announced the opening of its Bucharest Technology Hub to reinforce Payscale’s commitment to AI-driven innovation with access to …
Payscale își extinde acoperirea globală cu Centrul Tehnologic din București
GlobeNewswire
·
July 1, 2025
BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Payscale Inc., cel mai mare furnizor de soluții de informații despre compensare, a anunțat astăzi deschiderea Centrului său Tehnologic din București pentru a consolida angajamentul Payscale față de inovația bazată …
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
GlobeNewswire
·
July 1, 2025
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of …